Sale!

MYO7A Gene Deafness Autosomal Recessive Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYO7A Gene Deafness Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MYO7A gene that are linked to a form of hereditary hearing loss. This condition, known as autosomal recessive nonsyndromic deafness type 2 (DFNB2), is characterized by a significant reduction in hearing that is not associated with other symptoms or syndromes. The MYO7A gene plays a crucial role in the development and maintenance of hair cells within the inner ear, which are essential for normal hearing.

This genetic test involves the collection of a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any mutations in the MYO7A gene. It is particularly valuable for families with a history of hearing loss, providing insights into the genetic basis of the condition and informing decisions about further management or intervention.

The cost of the MYO7A Gene Deafness Autosomal Recessive Type 2 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to accurately identify mutations in the MYO7A gene, offering a crucial resource for affected individuals and their families seeking to understand the genetic underpinnings of their hearing loss.

Description

MYO7A Gene Deafness Autosomal Recessive Type 2 Genetic Test

Test Name: MYO7A Gene Deafness Autosomal Recessive Type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A8

Test Details:

The MYO7A gene is responsible for producing a protein called myosin 7A, which is involved in the function of hair cells in the inner ear. Mutations in the MYO7A gene can lead to a condition known as deafness, autosomal recessive type 2 (DFNB2). DFNB2 is a form of genetic deafness that is inherited in an autosomal recessive manner, meaning that both copies of the MYO7A gene must have mutations in order for the individual to be affected. This condition is characterized by profound hearing loss from birth, with individuals typically having little to no residual hearing.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of MYO7A gene deafness, NGS genetic testing can be used to identify mutations or variants in the MYO7A gene that may be responsible for the individual’s hearing loss. By identifying the specific genetic cause of deafness in an individual, NGS genetic testing can provide important information for diagnosis, prognosis, and potential treatment options. It can also help in genetic counseling and family planning by identifying individuals who may be carriers of the MYO7A gene mutation.

It’s important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support.

Test Name	MYO7A Gene Deafness autosomal recessive type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ear Nose Throat Disorders
Doctor	ENT Doctor
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A8
Test Details	The MYO7A gene is responsible for producing a protein called myosin 7A, which is involved in the function of hair cells in the inner ear. Mutations in the MYO7A gene can lead to a condition known as deafness, autosomal recessive type 2 (DFNB2). DFNB2 is a form of genetic deafness that is inherited in an autosomal recessive manner, meaning that both copies of the MYO7A gene must have mutations in order for the individual to be affected. This condition is characterized by profound hearing loss from birth, with individuals typically having little to no residual hearing. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of MYO7A gene deafness, NGS genetic testing can be used to identify mutations or variants in the MYO7A gene that may be responsible for the individual’s hearing loss. By identifying the specific genetic cause of deafness in an individual, NGS genetic testing can provide important information for diagnosis, prognosis, and potential treatment options. It can also help in genetic counseling and family planning by identifying individuals who may be carriers of the MYO7A gene mutation. It’s important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support.